Literature DB >> 29708786

Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.

Azusa Kitao1, Osamu Matsui1, Norihide Yoneda1, Ryuichi Kita2, Kazuto Kozaka1, Satoshi Kobayashi1, Toshifumi Gabata1.   

Abstract

OBJECTIVE: The purpose of this study is to identify points useful in the imaging differentiation of hepatocellular carcinoma (HCC) showing hyperintensity on the hepatobiliary phase of gadoxetic acid-enhanced MRI and focal nodular hyperplasia (FNH) and FNH-like nodules.
MATERIALS AND METHODS: We enrolled consecutive 51 pathologically diagnosed HCCs that were hyperintense on hepatobiliary phase imaging (47 patients, including 44 with cirrhosis) and 10 FNHs and eight FNH-like nodules (16 patients, including five with cirrhosis). Imaging findings of dynamic CT and gadoxetic acid-enhanced MRI were assessed by two radiologists and compared between HCC and FNH.
RESULTS: The apparent diffusion coefficient (ADC) was lower in hyperintense HCC than in FNH (p = 0.004). The enhancement patterns of hyperintense HCC and FNH at dynamic CT were significantly different (p < 0.0001), with 95.9% of HCCs and 22.2% of FNHs showing arterial phase enhancement with a washout pattern, and 4.1% of HCCs and 77.8% of FNHs showing arterial phase enhancement without a washout pattern. The frequency of coronalike enhancement was 84.3% in hyperintense HCCs versus 11.1% in FNHs (p < 0.0001). The signal distribution on the hepatobiliary phase was significantly different between hyperintense HCCs and FNHs (p = 0.0002). The frequency of a capsulelike rim was 88.2% versus 22.2%, that of a mosaic appearance was 72.5% versus 11.1%, and that of a central scar was 0% versus 55.6% in hyperintense HCCs versus FNHs (all p < 0.0001). Multivariate logistic regression analysis showed that ADC ratio (p = 0.03; odds ratio, 0.12) and enhancement pattern at dynamic CT (p = 0.04; odds ratio, 16.21) were the independent factors for differentiation between hyperintense HCC and FNH.
CONCLUSION: For the diagnosis of hyperintense HCC differentiated from FNH and FNH-like nodule, arterial phase enhancement and washout pattern at dynamic CT and decrease of ADC ratio would be important findings.

Entities:  

Keywords:  CT; MRI; focal nodular hyperplasia; gadoxetic acid; hepatocellular carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29708786     DOI: 10.2214/AJR.17.19341

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Doughnut-like hyperintense nodules on hepatobiliary phase without arterial-phase hyperenhancement in cirrhotic liver: imaging and clinicopathological features.

Authors:  Kazuto Kozaka; Satoshi Kobayashi; Norihide Yoneda; Azusa Kitao; Kotaro Yoshida; Dai Inoue; Takahiro Ogi; Wataru Koda; Yasunori Sato; Toshifumi Gabata; Osamu Matsui
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

2.  Deep Learning for Approaching Hepatocellular Carcinoma Ultrasound Screening Dilemma: Identification of α-Fetoprotein-Negative Hepatocellular Carcinoma From Focal Liver Lesion Found in High-Risk Patients.

Authors:  Wei-Bin Zhang; Si-Ze Hou; Yan-Ling Chen; Feng Mao; Yi Dong; Jian-Gang Chen; Wen-Ping Wang
Journal:  Front Oncol       Date:  2022-05-26       Impact factor: 5.738

3.  Surgical indications for focal nodular hyperplasia of the liver: Single-center experience of 48 adult cases.

Authors:  Jin-Min Jung; Shin Hwang; Ki-Hun Kim; Chul-Soo Ahn; Deok-Bog Moon; Tae-Yong Ha; Gi-Won Song; Dong-Hwan Jung
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-02-28

Review 4.  Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.

Authors:  Federica Vernuccio; Domenico Salvatore Gagliano; Roberto Cannella; Ahmed Ba-Ssalamah; An Tang; Giuseppe Brancatelli
Journal:  Insights Imaging       Date:  2021-01-12

5.  Robotic resection of liver focal nodal hyperplasia guided by indocyanine green fluorescence imaging: A preliminary analysis of 23 cases.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Xiang-Long Tan; Zi-Zheng Wang; Qu Liu; Zhi-Ming Zhao
Journal:  World J Gastrointest Oncol       Date:  2020-12-15

6.  An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.

Authors:  Jelena Djokic Kovac; Aleksandar Ivanovic; Tamara Milovanovic; Marjan Micev; Francesco Alessandrino; Richard M Gore
Journal:  Radiol Oncol       Date:  2021-01-29       Impact factor: 2.991

7.  HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.

Authors:  Timo Alexander Auer; Thula Walter-Rittel; Dominik Geisel; Wenzel Schöning; Moritz Schmelzle; Tobias Müller; Bruno Sinn; Timm Denecke; Bernd Hamm; Uli Fehrenbach
Journal:  BMC Med Imaging       Date:  2021-02-15       Impact factor: 1.930

8.  Comparison of the Value of Color Doppler Ultrasound and Multislice Spiral CT in the Differential Diagnosis of Benign and Malignant Nodules in the Liver.

Authors:  Peiwan Jia; Ruirong Liu; Yun Liu; Yanyan Wu; Ting Dou
Journal:  Contrast Media Mol Imaging       Date:  2022-02-02       Impact factor: 3.161

Review 9.  Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.

Authors:  Yeun-Yoon Kim; Mi-Suk Park; Khalid Suliman Aljoqiman; Jin-Young Choi; Myeong-Jin Kim
Journal:  Clin Mol Hepatol       Date:  2019-01-21

10.  A CT-based radiomics nomogram for differentiation of focal nodular hyperplasia from hepatocellular carcinoma in the non-cirrhotic liver.

Authors:  Pei Nie; Guangjie Yang; Jian Guo; Jingjing Chen; Xiaoli Li; Qinglian Ji; Jie Wu; Jingjing Cui; Wenjian Xu
Journal:  Cancer Imaging       Date:  2020-02-24       Impact factor: 3.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.